Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2011-05-24
2011-05-24
Chang, Celia (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S317000, C514S326000, C514S408000, C546S212000, C546S231000, C548S471000, C548S527000
Reexamination Certificate
active
07947730
ABSTRACT:
Compounds of formula Iin salt or zwitterionic form wherein, wherein R1, R2, R3, R4, R5, J, L and M have the meanings as indicated in the specification, are useful for treating conditions that are mediated by the muscarinic M3 receptor. Pharmaceutical compositions that contain the compounds and a process for preparing the compounds are also described.
REFERENCES:
patent: 2746966 (1956-05-01), Biel et al.
patent: 3240784 (1966-03-01), Flick et al.
patent: 4447439 (1984-05-01), Nishimura et al.
patent: 6307060 (2001-10-01), Noe et al.
patent: 7399861 (2008-07-01), Bodor
patent: 0 073 645 (1983-03-01), None
patent: 1 302 458 (2003-04-01), None
patent: 0823423 (2004-06-01), None
patent: 92/06958 (1992-04-01), None
patent: WO 98/21183 (1998-05-01), None
patent: 03/087094 (2003-10-01), None
Prat et al. “Preparation of acyloxypyrrolidinium . . . ” CA 139:337885 (2003).
Kutsuma, et al., “1-(1,3-Dioxoan-4-ylmethyl)piperdinol Derivatives”, Chemical Abstracts, Database Accession No. 1978:6859 and JP 52 083763, Jul. 12, 1977.
Kutsuma et al., “Stereoisomers of 4-acyloxy-1-alkyl-1-(1,3-dioxoran-4-ylmethyl)piperidinium Salt Derivatives”, Chemical Abstracts, Database Accession No. 1979:405219 and JP 54 027570, Mar. 1, 1979.
“4-Acyloxy-1-(1,3-dioxolan-2-ylmethyl)piperidine Derivatives”, Chemical Abstracts, Database Accession No. 1981:603921 and JP 56 079688, Jun. 30, 1981.
“.Alpha.-Cyclic Aminophenylacetic Acid Esters and Their Quarternary Ammonium Salts”, Chemical Astracts, Database Accession No. 1984:120902 and JP 58 208270, Dec. 3, 1983.
Yoshida et al., “Structure-Activity Relationship of 3- and 4-acyloxy-1-(1,3-dioxolan-4-ylmethyl)piperidine Derivatives”, Chemical and Pharmaceutical Bulletin, vol. 33, No. 2, pp. 818-822 (1985).
Sugai et al., “Studies on Spasmolytics. II. Synthesis and Anticholinergic Activities of 4-acyloxy-1-alkyl-1-(1,3-dioxolan-4-ylmethyl)piperidinium Compounds”, Chemical and Pharmaceutical Bulletin, vol. 32, No. 3, pp. 977-985 (1984).
Sugai et al., “Studies on Spasmolytics. III. Synthesis and Anticholinergic Activityof 4-(acyloxy)-1-(1,3-dioxolan-2-ylmethyl)piperidines and Their Quarternary Salts”, Chemical and Pharmaceutical Bulletin, vol. 32, No. 3, pp. 1126-1134 (1984).
Kajiwara et al., “Studies on Spasmolytics. VI. Pharmacological Studies of Stereoisomeric 1,4-trans- and . . . ”, Chemical Abstracts, Database Accession No. 1986:14939 and Yakugaku Zasshi, vol. 105, No. 10, pp. 983-989 (1985).
Waelbroeck et al., “Binding Properties of Nine 4-diphenyl-acetoxy-N-methylpiperidine (4-DAMP) Analogs to M1, M2, M3 and Putative M4 Muscarinic Receptor Subtypes”, British Journal of Pharmacology, vol. 105, No. 1, pp. 97-102 (1992).
Freeman, “Antispasmodics IV. Further basic alkyl ester acid addition & quaternary ammonium salts”, J. Am. Pharm. Assoc., vol. XLV, No. 8, pp. 578-581, (1956).
Abstract of Ji et al., “Studies on a soft glycopyrrolate analog SG-1”, Pharmazie, vol. 57, No. 2, pp. 138-141, (2002).
Barlow et al., “A further search for selective antagonists at M2 muscarinic receptors”, Br. J. Pharmacol., vol. 89, No. 4, pp. 837-843, (1986).
Baettig Urs
Collingwood Stephen Paul
McCarthy Clive
Chang Celia
McAvoy Cozette M
Novartis AG
LandOfFree
Piperidinium and pyrrolidinium derivatives as ligands for... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Piperidinium and pyrrolidinium derivatives as ligands for..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Piperidinium and pyrrolidinium derivatives as ligands for... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2657064